SecBot SecBot

TLPPF

Telix Pharmaceuticals Ltd
OTC· Pharmaceutical Preparations· Inc. C3· CIK 0002007191 Biotech & Drug Discovery
$8.75 −0.40 (−4.38%)
Oct 26 4:00 PM ET · prev $9.15
1 year
−19.1%
from $10.82 · Oct 27
30 days
−29.4%
from $12.40
52-week range
$6.50–12.55
−30% from high · low Feb 9
Avg volume 20D
813
Oct 23 spike 5.9K
Short interest
🔒 Subscribers only
Filing reports
10
analyzed by SecBot
SecBot read MIXED 5 reports · latest
Balance 0 bearish · 0 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 5/5
Strongest NEUTRAL Telix Pharmaceuticals filed its Annual General Meeting (AGM) materials on May 21, 2026, including…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • TrendDOWNTREND

    21% below its 50-day average.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
May 21, 2026 SEC
Telix Pharmaceuticals filed its Annual General Meeting (AGM) materials on May 21, 2026, including Chairman/CEO…
6-K — Impact 2/10
May 18, 2026 SEC
David N. Gill filed a Form 3 initial statement of beneficial ownership with the SEC, reporting no securities…
3 — Impact 2/10
May 18, 2026 SEC
William Jellison filed a Form 3 initial statement of beneficial ownership with Telix Pharmaceuticals Ltd, reporting no…
3 — Impact 2/10

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short

Washington

Corporate Lobbying

12 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

SecBot reports

10 filings · 4 bullish · 0 bearish · 6 neutral
All TLPPF filing & press-release reports (10)